CytomX Therapeutics (CTMX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to -$5.5 million.
- CytomX Therapeutics' Other Gross PP&E Adjustments rose 4893.71% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 4893.71%. This contributed to the annual value of $9.9 million for FY2024, which is 22247.86% up from last year.
- Latest data reveals that CytomX Therapeutics reported Other Gross PP&E Adjustments of -$5.5 million as of Q3 2025, which was up 4893.71% from -$7.3 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Other Gross PP&E Adjustments registered a high of $9.9 million during Q4 2024, and its lowest value of -$23.0 million during Q2 2021.
- Over the past 5 years, CytomX Therapeutics' median Other Gross PP&E Adjustments value was -$14.0 million (recorded in 2023), while the average stood at -$13.4 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 737.65% in 2021, then skyrocketed by 22247.86% in 2024.
- Quarter analysis of 5 years shows CytomX Therapeutics' Other Gross PP&E Adjustments stood at -$15.0 million in 2021, then rose by 25.08% to -$11.2 million in 2022, then grew by 28.1% to -$8.1 million in 2023, then surged by 222.48% to $9.9 million in 2024, then tumbled by 156.2% to -$5.5 million in 2025.
- Its last three reported values are -$5.5 million in Q3 2025, -$7.3 million for Q2 2025, and -$8.0 million during Q1 2025.